Livingstone, Ann http://orcid.org/0000-0002-6836-0382
Howard, Kirsten http://orcid.org/0000-0002-0918-7540
Menzies, Alexander M. http://orcid.org/0000-0001-5183-7562
Long, Georgina V. http://orcid.org/0000-0001-8894-3545
Stockler, Martin R. http://orcid.org/0000-0003-3793-8724
Morton, Rachael L. http://orcid.org/0000-0001-7834-0572
Funding for this research was provided by:
National Health and Medical Research Council (NHMRC 1168194)
Cancer Institute NSW
Melanoma Institute Australia
University of Sydney
University of Sydney
Article History
Accepted: 18 May 2023
First Online: 23 June 2023
Declarations
:
: Funding for this work was provided by the Australian National Health and Medical Research Council (NHMRC 1168194), Cancer Institute New South Wales, Melanoma Institute Australia, Sydney Catalyst, Nicholas and Helen Moore, and the University of Sydney.
: AL, RLM and KH have no financial disclosures. AMM served on BMS, MSD, Novartis, Roche, Pierre-Fabre and QBiotics advisory boards. GVL is a consultant advisor for Amgen, Array Biopharma, Boehringer Ingelheim, BMS, Hexel AG, Highlight Therapeutics SL, MSD, Novartis, Pierre-Fabre, Provectus, QBiotics, Regeneron Pharmaceuticals and Specialised Therapeutics Australia. MRS received institutional research support from Amgen, Astellas, AstraZeneca, Bayer, Bionomics, BMS, Celgene, Medivation, MSD, Pfizer, Roche, Sanofi and Tilray but did not sit on any advisory boards.
: The Sydney Local Health District Human Research Ethics Committee (HREC/18/RPAH/736) granted ethics approval.
: All participants provided written consent; the Declaration of Helsinki underpinned this study [CitationRef removed].
: De-identified datasets used and analysed during the current study may be available from the corresponding author if the request falls within the project’s ethics approval.
: AL: conceptualisation, methodology, resources, writing – original draft preparation; KH: supervision, assistance with DCE methodology, writing, critical review/editing; AMM: supervision, assistance with participant recruitment, writing, critical review/editing, GVL: assistance with participant recruitment, critical review/editing; MRS: supervision, writing, critical review/editing, RLM: conceptualisation, supervision, assistance with DCE methodology, resources, writing, critical review/editing.